VAMP2 and major depressive disorder: Increased expression of VAMP2 in subjects with MDD is in line with preclinical evidence for glucocorticoid-mediated calcium influx increases in hippocampal CA regions which perturbs plasticity, potentially resulting in poorer cognitive performance [91].